E.M. Huber
- Oncology top 5%
- Peptidase Inhibition and Analysis 15
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 18
- Glycosylation and Glycoproteins Research 10
- Genomics, phytochemicals, and oxidative stress 4
- Fungal and yeast genetics research 4
- RNA and protein synthesis mechanisms 3
- Cell Biology top 10%
- Endoplasmic Reticulum Stress and Disease 4
- Hematology top 10%
-
- Click Chemistry and Applications 3
- Co-authors
- M. GrollWolfgang HeinemeyerMarcus GroettrupChristopher J. KirkRicarda SchwabMichael BaslerAxel A. BrakhageGerjan de Bruin
- Journals
- Angewandte Chemie International Edition (7 papers)Structure (6 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- GermanySwitzerlandAustria
In The Last Decade
E.M. Huber
40 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 99
- Oncology 527
- Molecular Biology 1.2k
- Cell Biology 171
- Immunology 167
- Hematology 84
Countries citing papers authored by E.M. Huber
This map shows the geographic impact of E.M. Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.M. Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.M. Huber more than expected).
Fields of papers citing papers by E.M. Huber
This network shows the impact of papers produced by E.M. Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.M. Huber. The network helps show where E.M. Huber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E.M. Huber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 9 | |
| 8 | 2021 | 20 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 18 | |
| 11 | 2019 | 28 | |
| 12 | 2018 | 14 | |
| 13 | 2017 | 27 | |
| 14 | 2017 | 20 | |
| 15 | 2016 | 30 | |
| 16 | 2016 | 94 | |
| 17 | 2015 | 15 | |
| 18 | 2014 | 49 | |
| 19 | 2009 | 26 | |
| 20 | 2008 | 18 |
About E.M. Huber
E.M. Huber is a scholar working on Oncology, Molecular Biology and Cell Biology, having authored 44 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (18 papers), Peptidase Inhibition and Analysis (15 papers), Glycosylation and Glycoproteins Research (10 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Fungal and yeast genetics research (4 papers), RNA and protein synthesis mechanisms (3 papers) and Click Chemistry and Applications (3 papers). The work is most often cited by research in Oncology (527 citations), Molecular Biology (1.2k citations) and Cell Biology (171 citations). E.M. Huber has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include M. Groll, Wolfgang Heinemeyer, Marcus Groettrup, Christopher J. Kirk, Ricarda Schwab, Michael Basler, Axel A. Brakhage, Gerjan de Bruin, Herman S. Overkleeft and J. Philip Karl. Their work appears in journals such as Angewandte Chemie International Edition, Structure, Journal of Medicinal Chemistry, Molecular Immunology and ChemBioChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.